Orthofix Medical Inc. (OFIX)
Automate Your Wheel Strategy on OFIX
With Tiblio's Option Bot, you can configure your own wheel strategy including OFIX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OFIX
- Rev/Share 20.53
- Book/Share 11.6948
- PB 0.9645
- Debt/Equity 0.4206
- CurrentRatio 2.7083
- ROIC -0.1498
- MktCap 441959424.0
- FreeCF/Share -0.1194
- PFCF -94.4253
- PE -3.0896
- Debt/Assets 0.2342
- DivYield 0
- ROE -0.2815
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | OFIX | Canaccord Genuity | -- | Buy | -- | $24 | Jan. 22, 2025 |
News
Orthofix Medical Inc. (OFIX) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Orthofix Medical Inc. (NASDAQ:OFIX ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Julie Dewey - Chief Investor Relations and Communications Officer Massimo Calafiore - President and Chief Executive Officer Julie Andrews - Chief Financial Officer Conference Call Participants Mathew Blackman - Stifel Caitlin Cronin - Canaccord Genuity Jeffrey Cohen - Ladenburg Operator Thank you for standing by. My name is Tina, and I will be your conference operator today.
Read More
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Negative
Orthofix (OFIX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.46 per share a year ago.
Read More
Orthofix Reports First Quarter 2025 Financial Results
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, updated its full-year 2025 net sales guidance, and reaffirmed its full-year 2025 non-GAAP adjusted EBITDA and positive free cash flow guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6-C™ and M6-L™ artificial disc product.
Read More
Kuehn Law Encourages Investors of Orthofix Medical Inc. to Contact Law Firm
Published: March 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Orthofix Medical Inc. (NASDAQ: OFIX) breached their fiduciary duties to shareholders.
Read More
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Published: February 17, 2025 by: Business Wire
Sentiment: Neutral
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT. Interested parties can access the live and archived webcast of the presentation in the “Events & Presentations” section of the Orthofix investor relations website at ir.orthofix.co.
Read More
About Orthofix Medical Inc. (OFIX)
- IPO Date 1992-04-24
- Website https://www.orthofix.com
- Industry Medical - Devices
- CEO Mr. Massimo Calafiore
- Employees 1616